| Literature DB >> 34166828 |
Giorgio Fiore1, Luigi Gianmaria Remore2, Leonardo Tariciotti2, Giorgio Giovanni Carrabba3, Luigi Schisano2, Mauro Pluderi3, Giulio Andrea Bertani3, Stefano Borsa3, Marco Locatelli4.
Abstract
OBJECTIVE: To assess organizational and technical difficulties of neurosurgical procedures during the coronavirus disease 2019 (COVID-19) pandemic and their possible impact on survival and functional outcome and to evaluate virological exposure risk of medical personnel.Entities:
Keywords: COVID-19; Neurosurgery; Neurosurgical outcome; SARS-CoV-2 infection; Urgent surgery
Year: 2021 PMID: 34166828 PMCID: PMC8216838 DOI: 10.1016/j.wneu.2021.06.071
Source DB: PubMed Journal: World Neurosurg ISSN: 1878-8750 Impact factor: 2.104
Patient Characteristics
| Prevalence | Preoperative KPS | Surgery Duration (minutes) | LOS (days) | Postoperative KPS | Complications | FU (months) | |
|---|---|---|---|---|---|---|---|
| Pathologies | |||||||
| Traumatic | 11 | 20 ± 15 | 90 ± 65 | 19 ± 11 | 40 ± 30 | 7 | 5 ± 2 |
| Infection | 4 | 20 ± 15 | 66 ± 26 | 44 ± 17 | 40 ± 15 | 4 | 5 ± 3 |
| Oncological | 2 | 20 | 142 ± 158 | 23 | 30 | 2 | 6 |
| Vascular | 6 | 10 | 65 ± 47 | 34 ± 5 | 15 ± 15 | 6 | 8 ± 2 |
| Hydrocephalus | 2 | 10 | 105 ± 64 | 12 | 50 | 2 | 12 |
| Surgical procedure | |||||||
| BH | 11 | 25 ± 15 | 55 ± 31 | 27 ± 17 | 45 ± 25 | 7 | 4 ± 3 |
| Craniotomy | 7 | 15 ± 10 | 155 ± 68 | 30 ± 8 | 40 ± 20 | 7 | 5 ± 3 |
| CSF shunting | 6 | 10 | 60 ± 46 | 26 ± 11 | 40 ± 10 | 6 | 9 ± 3 |
| Spine surgery | 1 | 30 | 80 | 38 | 30 | 1 | 9 |
KPS, Karnofsky performance status; LOS, length of stay; FU, follow-up; BH, burr hole; CSF, cerebrospinal fluid.
Number of patients with any complication type (see Table 4 for more information).
Preoperative Variables
| Patient | Age (years)/Sex | Type of Pathology | Pathology | Type of Surgery | Preoperative Neurological Status | Preoperative KPS |
|---|---|---|---|---|---|---|
| 1 | 47/F | Trauma | CSDH | BH | Confused, hemisyndrome | 50 |
| 2 | 57/M | Trauma | CSDH | BH | Aphasic, hemisyndrome | 40 |
| 3 | 60/M | Infection | Brain abscess | Craniotomy | Aphasic, hemisyndrome | 40 |
| 4 | 81/F | Trauma | CSDH | BH | Aphasic, hemisyndrome | 40 |
| 5 | 1/M | Hydrocephalus | Obstructive hydrocephalus | CSF shunting | Coma | 10 |
| 6 | 1/M | Hydrocephalus | Shunt malfunction | CSF shunting | Coma | 10 |
| 7 | 75/M | Infection | Brain abscess | BH | Aphasic, hemiparetic, seizures | 10 |
| 8 | 75/M | Infection | Brain abscess | BH | Aphasic, hemiparetic, seizures | 10 |
| 9 | 57/M | Oncology | HGG | BH | Hemisyndrome | 20 |
| 10 | 57/M | Oncology | HGG | Craniotomy | Hemisyndrome | 20 |
| 11 | 83/M | Trauma | CSDH | BH | Aphasic, hemisyndrome | 30 |
| 12 | 83/M | Trauma | CSDH | BH | Aphasic, incoming seizures | 10 |
| 13 | 83/M | Trauma | CSDH | BH | Aphasic, incoming seizures | 10 |
| 14 | 78/F | Trauma | CSDH | BH | Confused, hemisyndrome | 30 |
| 15 | 82/F | Trauma | CSDH | BH | Aphasic, hemisyndrome | 30 |
| 16 | 52/M | Vascular | Cerebellar hemorrhage | CSF shunting | Coma | 10 |
| 17 | 50/F | Vascular | SAH | CSF shunting | Coma | 10 |
| 18 | 58/M | Infection | Lumbar epidural empyema | Spinal surgery | Paraparesis | 30 |
| 19 | 33/M | Trauma | Gunshot brain injury | Craniotomy | Coma | 10 |
| 20 | 59/M | Vascular | Cerebellar hemorrhage | CSF shunting | Coma | 10 |
| 21 | 49/M | Trauma | AEH | Craniotomy | Coma | 10 |
| 22 | 71/F | Vascular | ICH | Craniotomy | Coma | 10 |
| 23 | 54/F | Vascular | SAH | CSF shunting | Coma | 10 |
| 24 | 45/M | Vascular | ICH | Craniotomy | Coma | 10 |
| 25 | 54/M | Trauma | ASDH | Craniotomy | Coma | 10 |
KPS, Karnofsky performance status; F, female; CSDH, chronic subdural hematoma; BH, burr hole; M, male; CSF, cerebrospinal fluid; HGG, high-grade glioma; SAH, subarachnoid hemorrhage; AEH, acute epidural hematoma; ICH, intracerebral hemorrhage; ASDH, acute subdural hematoma.
Postoperative Variables
| Patient | Surgery Time (minutes) | LOS (days) | Discharge Destination | KPS at Discharge | OC | FU (months) |
|---|---|---|---|---|---|---|
| 1 | 60 | 6 | Home | 100 | Improved | 3 |
| 2 | 85 | 14 | Home | 90 | Improved | 4 |
| 3 | 95 | 22 | Home | 60 | Improved | 3 |
| 4 | 135 | 9 | Home | 50 | Improved | 8 |
| 5 | 60 | 12 | Home | 50 | Improved | 12 |
| 6 | 150 | 12 | Home | 50 | Improved | 12 |
| 7 | 50 | 57 | Rehabilitation | 30 | Improved | 3 |
| 8 | 40 | 57 | Rehabilitation | 30 | Improved | 3 |
| 9 | 30 | 23 | Rehabilitation | 30 | Improved | 6 |
| 10 | 254 | 23 | Rehabilitation | 30 | Improved | 6 |
| 11 | 30 | 23 | Rehabilitation | 30 | Unchanged | 2 |
| 12 | 35 | 23 | Rehabilitation | 30 | Improved | 2 |
| 13 | 30 | 23 | Rehabilitation | 30 | Improved | 2 |
| 14 | 45 | 23 | Rehabilitation | 30 | Unchanged | 4 |
| 15 | 60 | 39 | Rehabilitation | 30 | Unchanged | 10 |
| 16 | 60 | 25 | Rehabilitation | 30 | Improved | 8 |
| 17 | 26 | 35 | Rehabilitation | 30 | Improved | 8 |
| 18 | 80 | 38 | Rehabilitation | 30 | Unchanged | 9 |
| 19 | 210 | 28 | Home | 50 | Improved | 3 |
| 20 | 46 | 35 | Rehabilitation | 30 | Improved | 3 |
| 21 | 95 | 25 | Hospice | 10 | Unchanged | 6 |
| 22 | 80 | — | — | — | Deceased | — |
| 23 | 25 | — | — | — | Deceased | — |
| 24 | 150 | — | — | — | Deceased | — |
| 25 | 200 | — | — | — | Deceased | — |
LOS, length of stay; KPS, Karnofsky performance status; OC, outcome comparison; FU, follow-up.
Patient Complications
| Patient | Type of Complication | ||||
|---|---|---|---|---|---|
| COVID-19 | Infectious | Surgical | Neurological | Others | |
| 1 | — | — | — | — | — |
| 2 | — | Phlebitis | — | — | — |
| 3 | PE | Bacterial pneumonia | — | — | Hyperglycemia |
| 4 | — | — | — | — | — |
| 5 | — | — | Shunt malfunction | Coma | — |
| 6 | — | — | — | Drug-resistant seizures | — |
| 7 | Pneumonia | Bacterial pneumonia | New drainage | Drug-resistant seizures | — |
| 8 | Pneumonia | Sepsis | — | — | — |
| 9 | Pneumonia | Bacterial pneumonia | — | — | Hyponatremia |
| 10 | Persistent positivity | Fever | — | — | — |
| 11 | — | — | CSDH relapse | Worsening hemiparesis | — |
| 12 | — | — | — | Drug-resistant seizures | — |
| 13 | — | — | — | — | — |
| 14 | — | — | — | — | — |
| 15 | — | Multidrug resistant bacterial colonization | — | — | AF |
| 16 | — | Bacterial pneumonia | — | — | — |
| 17 | — | Bacterial pneumonia | — | Hydrocephalus | — |
| 18 | — | Spondylodiscitis | Arthrodesis | — | Pleural effusion |
| 19 | — | Bacterial pneumonia | — | — | — |
| 20 | ARDS, DVT | — | — | — | — |
| 21 | — | Sepsis | — | — | HRS |
| 22 | — | — | — | — | Death |
| 23 | — | — | — | — | Death |
| 24 | — | — | — | — | Death |
| 25 | — | — | — | — | Death |
COVID-19, coronavirus disease 2019; PE, pulmonary embolism; CSDH, chronic subdural hematoma; AF, atrial fibrillation; ARDS, acute respiratory distress syndrome; DVT, deep venous thrombosis; HRS, hepatorenal syndrome.